Medical and Pharmaceutical

KB707 demonstrated a 27% objective response rate and 73% disease control rate

More treatment innovation just in time for the holidays

The stock went up by over 185% after the LOI was announced

Denifanstat received FDA Breakthrough Therapy designation for metabolic dysfunction-associated steatohepatitis

This UK oncology company was spun out from the University of York's Department of Biology

It will examine the efficacy of 'eftilagimod alfa' in conjunction with Merck's Keytruda drug and chemo

Usage of the therapeutic resulted in unhealthy levels of transaminases (liver enzymes) in participants

It is not the first pee test used to help diagnose the disease, but it is the first of its kind

For 63 per cent of patients, the cancer was either reduced or kept from worsening

Its 'VisiRad XR' X-ray assessment system is FDA-approved and assisted by Google Cloud's Vertex AI platform

Kentucky has the highest rate of the disease in the country, largely attributable to a vast number of smokers

This unfortunate incident occurred during a study on the company's Rett syndrome therapeutic NGN-401

The first patient has been screened with the R&D-stage test in a Phase III study

It is being led by Seoul's bioscience company J INTS BIO

Cytalux was invented by a researcher from Purdue University in Indiana

It works by identifying abnormal levels of isoprene -- a volatile organic compound

The achievement was announced as Lung Cancer Awareness Month begins

This pharmaceutical company is also developing a synthetic cannabinoid drug to treat anxiety and cognitive decline

This €4.9-million-euro initiative is being funded by the Irish Cancer Society

Lazertinib, developed in partnership with Janssen Biotech, received FDA approval in August

Analysts at Cantor Fitzgerald and JP Morgan Chase & Co recently gave the company an overweight rating

It is being implemented before Lung Cancer Awareness Month in November

Studies by the institution have shown that Indigenous people in the U.S. have a 73% higher cancer mortality rate than others

Developing drugs for the treatment of epilepsy, depression, obesity and other conditions is the company's forte

Lung cancer remains the leading cause of cancer-related deaths in Canada, effecting one in 14 Canadians

Some studies have indicated that it can, along with other cancers

The Swiss oncology company's stock rose by over 33% as a result

RNA editing involves modifying RNA to correct or alter protein production in the body

Tylee Craft was diagnosed with stage 4 large cell neuroendocrine carcinoma in 2022

The Israeli company has used its proprietary Alpha DaRT treatment for other cancers but not lung

The University of California says 15 veterans die from lung cancer around the world every day

The SAPPHIRE study demonstrated statistically significant and clinically meaningful improvements

The consortium is affiliated with the World Health Organization

The biotech company will be revealing 3-year safety data on its primary drug for Duchenne muscular dystrophy next week

About 900,000 are at risk of contracting the disease, the department says

The state is tailoring its program after Kentucky's successful model

The study analyzed CT scans from over 10,000 participants and found at least one lung nodule in 42 per cent of them

The biotech company is giving up on a leukemia drug and shifting focus to a bowel disease treatment

This oncology tech company has created the proprietary "Proclarix" blood test for diagnosing prostate cancer

These trucks will complete thousands of CT scans and pulmonary function tests annually